A carregar...

Potential biomarkers to follow the progression and treatment response of Huntington’s disease

Huntington’s disease (HD) is a rare genetic disease caused by expanded polyglutamine repeats in the huntingtin protein resulting in selective neuronal loss. Although genetic testing readily identifies those who will be affected, current pharmacological treatments do not prevent or slow down disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Med
Main Authors: Disatnik, Marie-Hélène, Joshi, Amit U., Saw, Nay L., Shamloo, Mehrdad, Leavitt, Blair R., Qi, Xin, Mochly-Rosen, Daria
Formato: Artigo
Idioma:Inglês
Publicado em: The Rockefeller University Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5110026/
https://ncbi.nlm.nih.gov/pubmed/27821553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20160776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!